高级检索

急性脑梗死患者高敏C反应蛋白及脂蛋白a表达水平的临床价值

Clinical value of hypersensitive C-reactive protein and lipoprotein (a) in acute cerebral infarction

  • 摘要: 目的: 探讨急性脑梗死患者与健康人群血高敏C反应蛋白(hs-CRP)及脂蛋白aLp(a)水平的变化, 并分析其可能的临床意义。方法: 采用免疫比浊法测定急性脑梗死患者及健康人群血hs-CRP及Lp(a水平)。对急性脑梗死患者进行影像学分型、NIHSS评分以及OCSP分型。采用SPSS 13.0对结果进行统计分析。结果: 急性脑梗死患者hs-CRP (7.79±1.12) mg/L, n=200明显高于健康组(0.59±1.12) mg/L, n=100, P< 0.05;急性脑梗死患者Lp(a) (265.32±19.86) mg/L, n=200明显高于健康组(30.49±1.72) mg/L, n=100, P< 0.05;急性脑梗死患者中前循环梗死患者hs-CRP (10.18±1.77) mg/L, n=114明显高于后循环梗死患者(4.62±1.01) mg/L, n=86, P< 0.05;前循环梗死患者Lp(a) (319.40±31.40) mg/L, n=114明显高于后循环梗死患者(193.64±17.42) mg/L, n=86, P< 0.05。NIHSS评分重度组(≥10分)hs-CRP (19.34±4.82) mg/L, n=25明显高于NIHSS评分轻度组(0~4分) (6.00±1.16) mg/L, n=143及中度组(5~9分) (6.87±2.14) mg/L, n=32, P< 0.05,其余各组间hs-CRP无差异;NIHSS评分各组Lp(a)差异无统计学意义。OCSP分型中TACI组hs-CRP (22.33±5.5) mg/L, n=21高于PACI组(9.32±2.76) mg/L, n=54、POCI组(6.01±1.75) mg/L, n=40及LACI组(4.02±0.79) mg/L, n=85, P< 0.05;其余各组间hs-CRP无差异;OCSP分型中各组Lp(a)无差异。结论: hs-CRP及Lp(a)是脑梗死独立危险因素,脑梗死组较健康对照组明显升高; Lp(a)在前循环脑梗死组高于后循环脑梗死组。hs-CRP与脑梗死的严重程度密切相关,对预后判断有一定的指导意义。

     

    Abstract: Objective: To detect the change of hypersensitive C-reactive protein (hs-CRP) and lipoprotein (a) (Lp (a)) between acute cerebral infarction patients and normal person. Also to study the different level of hs-CRP and Lp (a) according to different classification of acute cerebral infarction. Methods: The level of hs-CRP and Lp (a) among acute cerebral infarction patients and normal person were measured by using immunoturbidimetry. NIHSS score and OCSP and MRI to classify the clinical symptom of acute cerebral infarction patients were undergone. SPSS 13.0 was used to analysis all the data. Results: The level of hs-CRP (7.79±1.12 mg/L, n=200) and Lp (a) (265.32±19.86 mg/L, n=200) of acute cerebral infarction were higher than that of normal person, hs-CRP (0.59±1.12 mg/L, n=100) and Lp (a) (30.49±1.72 mg/L, n=100) respectively (P< 0.05). The level of hs-CRP (10.18±1.77 mg/L, n=114) and Lp (a)(319.40±31.40 mg/L, n=114) of anterior circulation infarction were higher than that of posterior circulation infarction, hs-CRP (4.62±1.01 mg/L, n=86)and Lp (a) (193.64±17.42 mg/L, n=86), respectively (P< 0.05). The level of hs-CRP(19.34±4.82 mg/L, n=25) from severe team (≥10) was higher than that of moderate team (5-9)(6.87±2.14 mg/L, n=32) and mild team (0~4)(6.00±1.16 mg/L, n=143) respectively, according to the score of NIHSS(P< 0.05). There were no statistic difference of Lp (a) among these three teams according to the score of NIHSS. According to the classification of OCSP, the level of hs-CRP of TACI (22.33±5.5 mg/L, n=21) was higher than that of PACI (9.32±2.76 mg/L, n=54), POCI(6.01±1.75 mg/L, n=40) and LACI(4.02±0.79 mg/L, n=85),respectively (P< 0.05). There was no statistic difference of Lp (a) among different teams according to OCSP. Conclusions: hs-CRP and Lp (a) are independent risk factors of the acute cerebral infarction. The level of hs-CRP and Lp (a) of acute cerebral infarction patients are higher than that of normal person. The level of Lp (a) of anterior circulation infarction is higher than that of posterior circulation infarction. This result may indicate that Lp (a) may have the value to indicate the position of acute cerebral infarction. The level of hs-CRP may have a relationship with severity of acute cerebral infarction and also it may have the value to indicate the position of acute cerebral infarction.

     

/

返回文章
返回